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Abstract Vanadate stimulates adipocyte 2-deoxyglucose trans-
port and GLUT-4 translocation to the membrane through an
insulin receptor-independent but wortmannin-inhibitable path-
way. Vanadate stimulates PI 3-kinase in anti-IRS-1 immuno-
precipitates and the binding between IRS-1 and the p85K subunit
of PI 3-kinase. In insulin-resistant adipocytes from old rats
vanadate fully stimulates IRS-1-associated PI 3-kinase, but
partially activates glucose uptake. We conclude that : (a)
vanadate stimulates 2-deoxyglucose uptake using a pathway
that converges with that of insulin at the level of PI 3-kinase; and
(b) adipocytes from old rats are defective in the insulin pathway
at steps located both upstream and downstream of PI 3-kinase.
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1. Introduction
The insulin-mimetic agent vanadate has been shown to re-
store normoglycemia in streptozotocin-treated diabetic rats
[1,2] and in experimental animals with type II diabetes [3^6]
after oral administration, and to improve insulin sensitivity in
the skeletal muscle of normal [7], obese [8], and aged rats [9],
an e¡ect resulting from stimulation of glucose uptake and
metabolism by tissues. In rat adipocytes and other intact cel-
lular systems vanadate is able to stimulate hexose uptake
[10,11], glucose oxidation [11,12], and glycogen synthase ac-
tivity [13], as well as to inhibit lipolysis [14]. Concerning the
mode of action of vanadate (5+ oxidation state), it has been
concluded that its e¡ects are not mediated by the stimulation
of insulin receptor autophosphorylation and kinase activity
[6,11,14,15], but the point of convergence with the insulin
signal remains to be elucidated. A recent report has shown
that vanadate stimulates a membranous non-receptor tyrosine
kinase in rat adipocytes that could mediate its e¡ects on glu-
cose uptake and lipolysis [16]. If vanadate can bypass the
early events of the insulin-dependent cascade, it could be used
as a powerful tool to investigate which steps in this cascade
are impaired in insulin-resistant cells.
Activation of phosphatidyl inositol 3-kinase (PI 3-kinase) is
a necessary step in insulin stimulation of glucose uptake and
glucose transporter 4 (GLUT-4) translocation and its inhibi-
tion by wortmannin is known to block these e¡ects [17^22].
Vanadate also stimulates glucose uptake in rat adipocytes
[10,11,14,23] and L6 myotubes [20], and wortmannin has
been shown to partially block its e¡ect on myotubes suggest-
ing the existence of PI 3-kinase-dependent and -independent
pathways in the mechanism of vanadate action.
In the present work we analyzed the vanadate e¡ect on
complex formation between the p85K subunit of PI 3-kinase
and insulin receptor substrate-1 (IRS-1), and the PI 3-kinase
activity associated with it, as well as the GLUT-4 transloca-
tion and glucose uptake in isolated adipocytes from 3-month-
old mature (not juvenile) rats, and explored whether it can
stimulate 2-deoxyglucose uptake in insulin-resistant adipo-
cytes from 24-month-old rats, which we have previously
shown to be extremely insulin-insensitive both in vivo [24]
and in vitro [25,26].
2. Materials and methods
2.1. Materials
Cytochalasin B was purchased from Aldrich Chemical (Wisconsin,
USA). Porcine insulin, sodium orthovanadate, wortmannin, quercetin,
phosphatidyl inositol, and protein A-Sepharose were from Sigma
Chemical (Missouri, USA). 2-Deoxy-D[1-3H]glucose, [Q-32P]ATP,
and the ECL method for Western blot were purchased from Amer-
sham (UK). Speci¢c polyclonal antibodies for the GLUT-4 protein
were prepared as in [27]. Anti-IRS-1, anti-p85K, and monoclonal
4G10 anti-phosphotyrosine antibodies were from UBI (New York,
USA). Polyclonal antibodies for the C-terminal domain of IR L-sub-
unit were from Santa Cruz Biotechnology (USA).
2.2. Animals
Male adult (3 months; body weight 408 þ 29 g) and old (24 months;
body weight 622 þ 22 g) Wistar rats fed ad libitum on a standard
laboratory chow and water were used throughout this study. The
characteristics of the two groups of rats have been previously reported
[24,25]. Adipocyte size was similar in both groups of animals [25].
2.3. Isolation of fat cells and determination of glucose uptake
Adipocytes were prepared by the collagenase method according to
[28]. Determination of glucose transport was based on previously
published procedures [29] with some modi¢cations. Brie£y, adipocytes
were washed three times in 1% bovine serum albumin/KRP bu¡er,
and subsequently incubated for 10 min in the same medium contain-
ing 3% bovine serum albumin in a proportion of 1 ml of cells per 3 ml
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of medium. 50 WM cytochalasin B or ethanol was added, and cells
were further incubated in the presence or absence of 160 nM insulin
or 1 mM Na3VO4 for 20 min. Wortmannin (1 WM) or quercetin (100
WM) was added 10 min before insulin or vanadate. Reaction was
started by addition of 4 WCi of 2-deoxy-D[1-3H]glucose (2 mM) and
after 6 min the medium was aspirated and cells were washed four
times with cold PBS. Aliquots of the cellular suspension were counted
for radioactivity, and carrier-mediated transport activity was calcu-
lated by subtracting the amount of radioactivity incorporated in the
presence of cytochalasin B, which was always lower than 30% of total
basal incorporation. Under the reaction conditions used, incorpora-
tion of 2-deoxyglucose was linear up to 10 min in cells preincubated
with 160 nM insulin, in agreement with data in [29]. Cells were
counted after staining with osmium tetroxide and the diameter was
determined as described in [25].
2.4. Isolation of adipocyte membrane fractions
Adipocytes incubated as described above were lysed in homogeni-
zation bu¡er (10 mM Tris-HCl, pH 7.4, 100 mM sucrose, 1 mM
EDTA, 50 mM NaF, 10 mM sodium pyrophosphate, 2 mM Na3VO4,
10 Wg/ml trypsin inhibitor, 1 mM PMSF) and centrifuged at 8000Ug
for 30 min. Pellets were used for the preparation of plasma membrane
and the supernatant was further centrifuged in order to sediment the
low density microsome (LDM) fraction as reported in [30]. Whole
membrane fraction was obtained by centrifugation of cell lysates at
200 000Ug for 70 min.
2.5. Measurement of immunoreactive GLUT-4 protein
10 Wg of protein from puri¢ed membrane fractions was resolved by
10% SDS-PAGE and then transferred to nitrocellulose membranes.
Membranes were blocked in PBS containing 5% fat skimmed dry milk
for 1 h and subsequently incubated for 3 h with the GLUT-4-speci¢c
antibody (dilution 1:3000) at room temperature. After washing the
membranes with 0.05% Tween 20 in PBS, goat anti-rabbit peroxidase-
conjugated IgG was added and immunolabeled bands were visualized
by the ECL method. GLUT-4 protein was quantitated by scanning
densitometry of autoradiographs whose exposure was in the linear
range.
2.6. Determination of PI 3-kinase and association between IRS-1
and p85K
Isolated adipocytes preincubated with 1.6 WM insulin or 1 mM
Na3VO4 for 10 min were homogenized as indicated above in homog-
enization bu¡er supplemented with 1% NP-40. Equal amounts of
protein (1 mg) were incubated overnight with anti-IRS-1 antibodies
(2 Wg/ml) and subsequently 50 Wl of protein A-Sepharose was added.
Pellets were washed as described in [31] and incubated in 15 mM
HEPES, pH 7.4, in presence of 50 WM adenosine, 0.2 mM Na3VO4,
0.1 mg/ml phosphatidyl inositol, 5 mM MgCl2, and 50 WM [Q-32P]ATP
(50 WCi) for 20 min. Lipid extraction and separation in silica gel plates
was performed as in [31]. PI 3-P was localized using a mixture of
phosphoinositides as markers, and 32P incorporation was visualized
and quantitated with a phosphorimager BAS 150. Association of
p85K to IRS-1 was determined after electrophoretic separation of
anti-IRS-1 immunoprecipitates and subsequent Western blotting
with anti-p85K antibodies.
2.7. Insulin receptor phosphorylation
50 Wg of adipocyte plasma membrane protein was resolved by elec-
trophoresis and transferred to nitrocellulose. Membranes were blotted
with anti-phosphotyrosine and anti-IR L-subunit antibodies respec-
tively.
3. Results
As demonstrated in Table 1, preincubation of adipocytes
from young mature rats with 1 mM vanadate stimulates the
initial rate of 2-deoxyglucose uptake twofold, an e¡ect similar
to that elicited by 160 nM insulin in these cells, and corre-
spondingly lower than that observed in small adipocytes from
juvenile rats [32]. Quercetin, an insulin receptor kinase inhib-
itor, suppressed the insulin e¡ect on glucose uptake without
altering the stimulatory action of vanadate con¢rming that
both e¡ectors act through pathways di¡ering, at least, at the
early events as previously reported [6,11,14,15].
Stimulation of glucose transport by insulin [33] and vana-
date [23] in rat adipocytes is known to be mainly due to the
recruitment of GLUT-4 carriers from an endocellular micro-
somal pool to the plasma membrane. Fig. 1 shows that 1 mM
vanadate and 160 nM insulin induce a similar increase in the
amount of GLUT-4 associated with the plasma membrane
fraction of young rat adipocytes (2.8 þ 0.3- and 3.4 þ 0.4-fold
stimulation respectively), in good agreement with their e¡ect
on 2-deoxyglucose uptake. In both cases a decrease in GLUT-
4 in the LDM pool was observed (not shown). Quercetin did
not modify the vanadate induced translocation of GLUT-4 to
the plasma membrane, but prevented that induced by insulin
(Fig. 2A,B) supporting further the existence of two separate
stimulatory pathways for both e¡ectors. Moreover, Fig. 1C
shows that the e¡ect of vanadate is not mediated by the IR.
Thus, in contrast to insulin, vanadate neither alters the phos-
photyrosine content of IR L-subunit nor induces a decrease in
IR amount in plasma membrane due to internalization.
Activation of PI 3-kinase has been identi¢ed as a crucial
step for the stimulation of glucose uptake and GLUT-4 trans-
location by insulin in rat adipose cells, 3T3-L1 adipocytes and
L6 myotubes [17^22]. Moreover, it has been suggested that
tyrosine phosphorylation of IRS-1 in response to insulin leads
to the association, activation, and targeting to intracellular
GLUT-4 containing vesicles, of PI 3-kinase [34]. As shown
in Table 1, the inhibitor of the PI 3-kinase catalytic activity
wortmannin completely abolishes the stimulation of 2-deoxy-
glucose uptake by insulin or vanadate in young rat adipocytes
suggesting that the signaling pathways of both agents con-
verge at the level of PI 3-kinase. Fig. 2A,B shows that wort-
mannin also inhibits the translocation of GLUT-4 to the plas-
ma membrane in response to vanadate or insulin. Moreover,
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Table 1
Stimulation of 2-deoxyglucose uptake in adipocytes from 3- and 24-
month-old rats
Experimental conditions Age
3 months 24 months
Insulin 2.18 þ 0.07 1.25 þ 0.04a
(n = 39) (n = 21)
insulin+quercetin 1.34 þ 0.14d n.d.
(n = 5)
Insulin+wortmannin 0.96 þ 0.08d n.d.
(n = 4)
Vanadate 1.95 þ 0.08 1.48 þ 0.03b;c
(n = 17) (n = 8)
Vanadate+quercetin 1.86 þ 0.15 1.38 þ 0.03b;c
(n = 6) (n = 4)
Vanadate+wortmannin 1.04 þ 0.12e 1.13 þ 0.06e
(n = 8) (n = 4)
Adipocytes were incubated in the presence or absence of 160 nM
insulin or 1 mM vanadate, and 2-deoxyglucose uptake was deter-
mined as indicated in Section 2. Wortmannin (1 WM) or quercetin
(100 WM) was added 10 min before insulin or vanadate where indi-
cated. Data are expressed as the quotient between 2-deoxyglucose
uptake in the presence and in the absence of e¡ectors, for each rat
age, and represent mean þ S.E. Basal 2-deoxyglucose uptake values
were 0.9 þ 0.1 and 1.1 þ 0.15 nmol of 2-deoxyglucose/min/105 cells
(P = NS) for young and old rat adipocytes, respectively. Values in
parentheses indicate the number of di¡erent experiments correspond-
ing to each experimental condition.
aP6 0.0001 vs. 3 months; bP6 0.0005 vs. 3 months; cP6 0.01 vs.
insulin; dP6 0.0005 vs. insulin; eP6 0.0002 vs. vanadate; n.d. = not
determined.
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as shown in Fig. 2C, vanadate 1 mM stimulates the PI 3-
kinase activity in anti-IRS-1 immunoprecipitates similarly to
insulin, and both e¡ectors promote the association of p85K,
the regulatory subunit of PI 3-kinase, to IRS-1 (Fig. 2D).
Since vanadate activates PI 3-kinase and its association to
IRS-1, GLUT-4 translocation, and 2-deoxyglucose uptake, it
seems interesting to investigate whether it can overcome the
insulin insensitivity of these cellular events in insulin-resistant
cells. Therefore, we explored the e¡ect of vanadate in isolated
adipocytes from old rats, a cell type previously reported to be
very insensitive to insulin [24^26]. As can be seen in Fig. 3A,
1 mM vanadate stimulates more than twofold the PI 3-kinase
activity of anti-IRS-1 immunoprecipitates from old rat adipo-
cytes, an e¡ect similar to that elicited in young rat cells by
both vanadate and insulin. In contrast, insulin causes only a
weak activation of this activity in adipocytes from old rats
(1.2-fold), a fact that correlates well with the low e¡ect of
the hormone on glucose uptake and GLUT-4 translocation
in these cells (Table 1 and Fig. 1A,B). Fig. 3B also shows
that 1 mM vanadate promotes the association of p85K to
IRS-1 to the same extent in adipocytes from young and old
rats, whereas insulin fails to induce this association in the
insulin-resistant adipocytes. The e¡ects of vanadate on cells
from aged animals also take place without stimulating IR
phosphorylation and internalization (Fig. 1C). These data
might indicate that in adipocytes from old rats the insulin
signal cascade is fully functional downstream of the stimula-
tion of IRS-1 binding to p85K and subsequent activation of PI
3-kinase activity, but is defective at an earlier step. However,
as shown in Table 1 and Fig. 1A,B, in adipocytes from old
rats vanadate stimulates only partially both GLUT-4 trans-
location to the plasma membrane and 2-deoxyglucose uptake,
suggesting that another signaling impairment exists down-
stream of PI 3-kinase. Wortmannin fully abolished the e¡ect
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Fig. 1. GLUT-4 translocation and IR phosphorylation. A: 50 Wg of plasma membrane protein from adipocytes incubated in the absence (B) or
presence of 160 nM insulin (I) or 1 mM vanadate (V) was resolved by 7.5% SDS-PAGE and GLUT-4 was detected by Western blotting as in-
dicated in Section 2. The ¢gure shows two representative experiments for young and old rat adipocytes respectively. B: Seven autoradiographs
like those in A were quantitated by densitometric scanning. The ¢gure represents the increase in GLUT-4 in the plasma membrane as fold
stimulation þ S.E., elicited by preincubation of adipocytes with insulin or vanadate. a: P6 0.002 vs. young; b: P = 0.05 vs. young; c: P = 0.05
vs. insulin. C: Plasma membrane proteins were resolved as in A. Phosphotyrosine content of IR L-subunit was detected by immunoblot with
anti-phosphotyrosine antibodies (upper part), and the amount of receptors in each case was estimated by immunoblot with anti-IR antibodies
(lower part) as described in Section 2.
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of vanadate in these cells (Table 1) indicating that it is medi-
ated through activation of PI 3-kinase.
Looking for changes in the signal pathway downstream of
PI 3-kinase we focused our attention in the study of the
GLUT-4 content and its distribution between membrane
pools in adipocytes from adult and old rats. By studying by
Western blot analysis (not shown) the relative amounts of
GLUT-4 in PM and LDM fractions we found that under
basal, unstimulated, conditions the equilibrium distribution
of GLUT-4 is shifted to the plasma membrane as demon-
strated by [GLUT-4]LDM/[GLUT-4]PM ratios of 7.9 þ 0.8
(n = 5) and 3.0 þ 0.5 (n = 9) for young and old rat adipocytes
respectively (P6 0.0002). Since basal glucose uptake rates are
similar for both cell populations, this di¡erence could be in-
terpreted as consequence of a decrease in the amount of car-
riers in the LDM fraction available for translocation. In fact,
the [GLUT-4] in LDM from old rat cells was estimated to be
46 þ 18% (n = 6) of that observed in fat cells from young ani-
mals. However, determination of GLUT-4 in whole mem-
brane fractions showed only a 25 þ 10% (n = 6) decrease in
adipocytes from old rats, suggesting that another membrane
pool is sequestering some carriers in the aged animals.
4. Discussion
Vanadate induces metabolic e¡ects similar to those elicited
by insulin in rat adipocytes and other insulin-sensitive cells,
but the molecular mechanism involved remains unclear. In the
present work we studied the molecular events induced by va-
nadate that lead to the stimulation of 2-deoxyglucose trans-
port in isolated adipocytes. Our data indicate that 1 mM
vanadate and 160 nM insulin are equally potent stimulators
of glucose uptake and GLUT-4 translocation to the plasma
membrane. However, whereas the insulin e¡ect is abolished by
the insulin receptor phosphotransferase inhibitor quercetin,
vanadate action appears to be quercetin-insensitive and does
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Fig. 2. E¡ect of vanadate and insulin on PI 3-kinase activity associated with IRS-1 and inhibition by wortmannin and quercetin of their e¡ects
on GLUT-4 translocation. A: E¡ect of preincubation with wortmannin or quercetin on GLUT-4 translocation induced by vanadate in adipo-
cytes from young animals. B: without e¡ectors; V: 1 mM vanadate; V+W: 1 mM vanadate+1 WM wortmannin; V+Q: 1 mM vanadate+100
WM quercetin. B: E¡ect of preincubation with wortmannin or quercetin on GLUT-4 translocation induced by insulin in adipocytes from young
animals. B: without e¡ectors; I: 160 nM insulin; I+W: 160 nM insulin+1 WM wortmannin; I+Q: 160 nM insulin+100 WM quercetin. C: Adi-
pocytes from young rats were incubated in the absence (B) or presence of insulin (I) and vanadate (V), and PI 3-kinase activity was determined
in anti-IRS-1 immunoprecipitates using phosphatidyl inositol as substrate (see Section 2). The lipid product PI 3-P was extracted and separated
by TLC and the 32P incorporation was detected by phosphorimager and autoradiography. D: 100 Wg of protein from adipocytes preincubated
without e¡ectors (B), or in presence of insulin (I) or vanadate (V), was immunoprecipitated with anti-IRS-1 antibodies and separated by SDS-
PAGE. Proteins were transferred to nitrocellulose and p85K was detected by blotting the membranes with anti-p85K antibodies.
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not involve IR phosphorylation and internalization as previ-
ously reported [6,11,14,15]. In contrast, the e¡ect of vanadate
and that of insulin were totally suppressed by preincubation
with the PI 3-kinase inhibitor wortmannin, suggesting the in-
volvement of this enzyme in the signaling pathway. In a pre-
vious study with L6 myotubes, wortmannin was shown to
inhibit only V60% of vanadate-activated glucose transport,
suggesting that it acts through PI 3-kinase-dependent and
-independent pathways [20]. In contrast, our data here dem-
onstrate that in rat adipose cells the e¡ect of vanadate on
glucose transport is mediated by stimulation of PI 3-kinase
with no evidence of PI 3-kinase-independent pathways, as is
the case for insulin.
Recent evidence supports that the acute redistribution of
intracellular glucose transporters to the plasma membrane in
response to insulin in rat adipocytes and 3T3-L1 adipose cells
is related to the formation of complexes containing IRS-1
bound to PI 3-kinase, which are targeted to the GLUT-4-
containing vesicles [34,35]. A very recent report has concluded
that vanadate stimulates PI 3-kinase activity in anti-phospho-
tyrosine immunoprecipitates from adipose cells [36]. Our data
in this work show for the ¢rst time that vanadate increases the
PI 3-kinase activity in anti-IRS-1 immunoprecipitates from rat
adipocytes, as well as the association of the p85K regulatory
subunit of the enzyme with IRS-1, as reported for insulin.
Whether vanadate acts by stimulation of IRS-1 phosphoryla-
tion through inhibition of a vanadate sensitive tyrosine phos-
phatase [37] remains to be elucidated. Recently, it has been
described that vanadate stimulates in vitro the autophospho-
rylation and kinase activity of a plasma membrane non-recep-
tor protein tyrosine kinase activity in rat adipocytes that as-
sociates with the p85K subunit of PI 3-kinase [16], postulating
a mechanism independent of IRS-1 for vanadate action on
glucose uptake. However, it is well known that membrane
tyrosine kinase receptors that bind directly PI 3-kinase after
ligand stimulation, such as PDGF receptor, do not stimulate
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Fig. 3. Stimulation by insulin and vanadate of PI 3-kinase activity and p85K association to IRS-1 in adipocytes from young and old rats. A:
Adipocytes from 3- and 24-month-old rats were preincubated in the absence or presence of insulin or vanadate and PI 3-kinase activity was
determined in anti-IRS-1 immunoprecipitates as indicated in Fig. 2C. Data represent the mean value þ S.E. of the stimulatory e¡ect elicited by
insulin and vanadate from seven di¡erent experiments performed separately with young and old rat adipocytes respectively. *P6 0.05 vs.
‘young+insulin’ and ‘old+vanadate’. B: Association of p85K with IRS-1 in adipocytes from young and old rats was determined as indicated in
Fig. 2D. Data show the stimulation of association over basal, induced by insulin or vanadate, and are the mean þ S.E. of seven and ¢ve inde-
pendent experiments performed with young and old rat adipocytes respectively. *P6 0.05 vs. ‘young+insulin’ and ‘old+vanadate’.
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glucose uptake and it seems unlikely that this vanadate-sensi-
tive kinase could do it. However, it might phosphorylate IRS-
1 in response to vanadate leading to the binding and activa-
tion of PI 3-kinase as reported here.
The former data indicate that vanadate shares part of the
insulin pathway leading to activation of glucose uptake, but
di¡ers at the early molecular events, making it a valuable tool
to localize which steps in the insulin pathway are impaired in
insulin-resistant cells. Using this approach to the study of the
insulin-resistant adipocyte from 24-month-old rats we demon-
strate here that the formation of complexes containing IRS-1
bound to p85K, as well as the PI 3-kinase activity associated
to IRS-1, are fully stimulated by vanadate in these cells, in
contrast to the poor e¡ect elicited by insulin. These data
would indicate that the impaired insulin action associated
with aging is likely due to a defective early step in the insulin
pathway. However, the fact that vanadate activates only par-
tially the GLUT-4 translocation and glucose transport in adi-
pose cells from old rats suggests that an additional defective
step in the pathway, downstream of PI 3-kinase, impairs the
vanadate and insulin action. Among the early molecular
events in the insulin signal cascade that could be impaired
in aged rats, autophosphorylation of insulin receptor and
stimulation of its kinase activity have been reported to be
decreased in vitro in adipocytes [25,26], and in vivo in liver
and muscle [38]. Carvalho et al. [38] also reported a progres-
sive decrease with aging of IRS-1 tyrosine phosphorylation in
response to insulin that strongly correlates with the decreased
phosphorylation of insulin receptor. A defective association
between IRS-1 and the p85K regulatory subunit of PI 3-kinase
due to intrinsic changes in any of both proteins seems unlikely
since vanadate elicits a normal stimulation of PI 3-kinase, and
the association of both molecules. Finally, changes in the
number and a⁄nity of insulin receptors during aging have
been previously ruled out [26].
Concerning the steps downstream of PI 3-kinase altered in
insulin-resistant adipocytes from old rats, there is evidence of
decreases in the number and the translocation of either cyto-
chalasin B binding sites [39], or speci¢c glucose carriers
[40,41], in aged rats. These data are in agreement with our
¢ndings indicating a 25% lower amount of GLUT-4 in adipo-
cytes from old animals, a decreased number of carriers in
LDM available for translocation, as well as a shift to the
plasma membrane in the equilibrium distribution of these
carriers under basal conditions.
In summary, we have shown that in rat adipocytes vanadate
stimulates the IRS-1 associated PI 3-kinase activity, and that
wortmannin fully inhibits the translocation of GLUT-4 to the
plasma membrane, and the increase of 2-deoxyglucose uptake,
suggesting a critical role for this activity in the vanadate path-
way. In insulin-resistant adipocytes from 24-month-old rats,
despite a normal stimulation of IRS-1 binding to p85K and PI
3-kinase activity, vanadate does not elicit a full activation of
glucose uptake probably due to the changes observed in the
number and distribution of GLUT-4 carriers that contribute
to the well characterized insulin resistance of these cells.
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